AHIP Statement for Senate HELP Committee Hearing on Prescription Drugs
posted by AHIP
on June 13, 2017
AHIP submitted this statement for the official record of a June 13 hearing in the Senate HELP Committee. Our statement focuses on: (1) the consequences out-of-control prescription drug prices have on consumers; (2) the actions health plans take to lower prescription drug costs, and how all consumers benefit from these savings through lower premiums and lower out-of-pocket costs; and (3) our recommendations for reducing prescription drug prices through market-based solutions that deliver real competition, create more consumer choice, and ensure that open and honest drug pricing is tied to the value delivered to patients.